Nomura Phase4 Ventures has led a $27m round in Albiero, a Swedish biotechnology company spun-out from AstraZeneca. TVM Capital and Scottish Widows have also invested in the business.
GP invests €4.7m in the France-based B2B leasing service to fuel international expansion
Foresight Group will provide an initial £5m revolving credit facility to Signature
Oliver Nell has joined the Munich office as flex equity partner and will focus on DACH investments
Cannabis data, conference and consulting service was backed by sector-focused investors